Harmony Biosciences Holdings (HRMY) Assets Average (2020 - 2026)

Harmony Biosciences Holdings has disclosed Assets Average across 7 years of filings, most recently posting $1.3 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $1.3 billion, up 23.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 23.79% YoY), and the FY2025 annual result was $1.1 billion, up 25.42% from the prior year.
• Assets Average came in at $1.3 billion for Q1 2026 at Harmony Biosciences Holdings, up from $1.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.3 billion in Q1 2026 to a low of $448.7 million in Q1 2022.
• The 5-year median for Assets Average is $829.2 million (2024), against an average of $851.7 million.
• Across the five-year window, Assets Average soared 59.77% in 2022 and grew 15.6% in 2024, its largest moves.
• Harmony Biosciences Holdings' Assets Average stood at $658.7 million in 2022, then advanced by 20.64% to $794.6 million in 2023, then rose by 21.28% to $963.7 million in 2024, then advanced by 28.67% to $1.2 billion in 2025, then climbed by 2.56% to $1.3 billion in 2026.
• The last three Assets Average figures came in at $1.3 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.